[Current results of hemostasis research (protein C, protein S) and their effect on oral anticoagulant therapy in clinical practice].
Gruber
A
A
Domján
G
G
Blaskó
G
G
Rákóczi
I
I
Petö
I
I
Sas
G
G
D000074:Acenocoumarol / Q000009:adverse effects; D000284:Administration, Oral; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced / Q000188:drug therapy; D004341:Drug Evaluation; D006023:Glycoproteins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011486:Protein C; D017293:Protein S; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000188:drug therapy; D013924:Thrombophlebitis / Q000139:chemically induced / Q000188:drug therapy*
D000925:Anticoagulants; D006023:Glycoproteins; D011486:Protein C; D017293:Protein S; D000074:Acenocoumarol
A haemostasis-kutatás újabb eredményei (protein C, protein S) és hatásuk az orális alvadásgátló kezelés gyakorlatára.